In breast cancer, glutamine uptake induces tamoxifen resistance via the PI3K–AKT–PTEN pathway49, while glutaminolysis contributes to CDK4/6 inhibitor resistance in esophageal squamous cancer50. Here, AKT1 is linked to breast cancer.